Evidence map›Paper›PMID 33249989›Full record

ArticleAutophagy2020

A multifactorial score including autophagy for prognosis and care of COVID-19 patients.

Marie-Angela Domdom, Patrick Brest, Iris Grosjean, Barnabé Roméo, Maria Teresa Landi, Jocelyn Gal, Daniel J Klionsky, Paul Hofman, Baharia Mograbi

Abstract read
In one paragraph

Article in Autophagy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. International journal of molecular sciences · 2021
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marie-Angela DomdomUniversité Côte d'Azur, CNRS, INSERM, IRCAN, FHU-OncoAge, Centre Antoine Lacassagne , Nice, France.ORCID 0000-0002-9896-6270
Patrick BrestUniversité Côte d'Azur, CNRS, INSERM, IRCAN, FHU-OncoAge, Centre Antoine Lacassagne , Nice, France.ORCID 0000-0002-1252-4747
Iris GrosjeanUniversité Côte d'Azur, CNRS, INSERM, IRCAN, FHU-OncoAge, Centre Antoine Lacassagne , Nice, France.ORCID 0000-0002-1017-8270
Barnabé RoméoUniversité Côte d'Azur, CNRS, INSERM, IRCAN, FHU-OncoAge, Centre Antoine Lacassagne , Nice, France.ORCID 0000-0001-6011-4868
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, MD, USA.ORCID 0000-0003-4507-329X
Jocelyn GalUniversity Côte d'Azur, Centre Antoine Lacassagne, Epidemiology and Biostatistics Department , Nice, France.ORCID 0000-0002-1802-118X
Daniel J KlionskyUniversity of Michigan, Department of Molecular, Cellular, and Developmental Biology, and Life Sciences Institute , Ann Arbor, MI, USA.ORCID 0000-0002-7828-8118
Paul HofmanUniversité Côte d'Azur, CNRS, INSERM, IRCAN, FHU-OncoAge, Centre Antoine Lacassagne , Nice, France.ORCID 0000-0003-0431-9353
Baharia MograbiUniversité Côte d'Azur, CNRS, INSERM, IRCAN, FHU-OncoAge, Centre Antoine Lacassagne , Nice, France.ORCID 0000-0002-1025-3429

Funding

The mechanism and regulation of autophagyR35GM131919 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DANIEL J. KLIONSKY · 2019 to 2026
$6.4M
NIGMS NIH HHS R35 GM131919
6 · The paper itself

Abstract

In less than eleven months, the world was brought to a halt by the COVID-19 outbreak. With hospitals becoming overwhelmed, one of the highest priorities concerned critical care triage to ration the scarce resources of intensive care units. Which patient should be treated first? Based on what clinical and biological criteria? A global joint effort rapidly led to sequencing the genomes of tens of thousands of COVID-19 patients to determine the patients' genetic signature that causes them to be at risk of suddenly developing severe disease. In this commentary, we would like to consider some points concerning the use of a multifactorial risk score for COVID-19 severity. This score includes macroautophagy (hereafter referred to as autophagy), a critical host process that controls all steps harnessed by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.

Indexed as

TranscriptomeAnimalsAutophagyAutophagy-Related ProteinsBiomarkersCOVID-19Genetic Predisposition to DiseaseHumansInfectious bronchitis virusMiceMiddle East Respiratory Syndrome CoronavirusMolecular Diagnostic TechniquesPrognosisResearch DesignRisk FactorsSARS-CoV-2Autophagy-Related ProteinsBiomarkersAntiviralautophagycoronavirusCovid-19intensive carepolygenic scorepolymorphismriskSARS-CoV-2screening testsusceptibilityvirophagy

Identifiers

PMID33249989
PMCPMC7751655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.